Immunoprecise Antibodies Ltd (IPA) — Financial Flexibility Index
Immunoprecise Antibodies Ltd (IPA) has a Financial Flexibility Index of -0.04x as of April 2025. Free cash flow of $-781.00K (operating CF $-1.14 Million minus capex $359.00K) represents 0% of total liabilities ($20.82 Million). Check IPA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunoprecise Antibodies Ltd Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for Immunoprecise Antibodies Ltd across 29 annual periods. See IPA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immunoprecise Antibodies Ltd (1997–2025)
Year-by-year free cash flow to debt coverage for Immunoprecise Antibodies Ltd. For the full company profile including market capitalisation, see IPA market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -92.6% |
| 2022 | -0.48x | $-8.66 Million | $-9.92 Million | $18.21 Million | ▼ -677.4% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▼ -1.6% |
| 2011 | -0.61x | $-66.73K | $-80.39K | $110.21K | ▼ -513.9% |
| 2010 | 0.15x | $14.32K | $-308.49K | $97.87K | ▼ -98.2% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -402.6% |
| 2007 | 3.69x | $1.53 Million | $-297.31K | $413.69K | ▼ -70.5% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +342.9% |
| 2003 | -0.64x | $-18.95K | $-168.38K | $29.53K | ▲ +55.6% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |